InSilicoTrials

About:

Modeling and Simulation to accelerate development and improve safety of drugs and medical devices and significantly cut R&D costs and time

Website: http://www.insilicotrials.com

Twitter/X: trials_in

Top Investors: StartUp Health, United Ventures, Pi Campus

Description:

InSilicoTrials is an emerging startup founded in 2018 by a team of life science, cybersecurity and digital innovation experts, which aims to revolutionize Healthcare through an innovative digital simulation platform, where complex computational simulations run in an easy and cost-effective way to hyper- accelerate drug & medical device development. We offer Pharma and MedTech companies state-of-the-art simulation tools that can highly reduce the cost and time of drugs & medical products’ development. The in silico technology can increase the quality of life of millions of patients by allowing cheaper treatments, bringing innovative drugs to the market in a shorter time, together with personalized cures and new solutions for rare diseases.

Total Funding Amount:

$6.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Trieste, Friuli-Venezia Giulia, Italy

Founded Date:

2018-05-04

Contact Email:

info(AT)insilicotrials.com

Founders:

Luca Emili, Roberta Bursi

Number of Employees:

11-50

Last Funding Date:

2020-09-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai